Male Health

Nanobiosensor Quickly Determining Type and Severity of Patient's Cancer

Nanobiosensor Quickly Determining Type and Severity of Patient's Cancer A team of investigators from the University of Toronto have used nanomaterials to develop an inexpensive microchip sensitive enough to quickly determine...

powered by

The Big Question: Are scientists now really able to make sperm and egg cells in the lab?

By Steve Connor, Science Editor Why are we asking this now? Scientists in the United States led by Renee Reijo Pera of Stanford University School of Medicine have made primitive sperm and egg cells from stem cells taken from...

powered by

Astellas and Medivation sign development agreement

Oct 29, 2009 (Datamonitor via COMTEX) -- Astellas Pharma, a Japanese pharmaceutical company, and Medivation, a US-based biopharmaceutical company, have entered into a global agreement to develop and commercialize MDV3100,...

powered by

Testicular Cancer Survivors Face Other Ills

WEDNESDAY, Oct. 28 (HealthDay News) -- For men with testicular cancer, survival comes at a price: New research suggests that those who recover from the disease face higher risks of long-term illness unrelated to tumors....

powered by

Protox Therapeutics to present Phase 2 study data of PRX302 for benign prostatic hyperplasia

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign...

powered by

The Real Reason Behind Sex-Related Performance Anxiety

Sex-related performance anxiety as a cause of erectile disorder, mental compartmentalization remedy, female attraction, emotional freedom technique, EFT for sexual dysfunction, positive affirmations to cure sexual problems,...

powered by

BioMed Realty Trust Extends Lease at Landmark With Progenics Pharmaceuticals

SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. announced today that it has entered into a new ten-year lease with Progenics Pharmaceuticals, Inc. encompassing approximately 148,000 square feet at The...

powered by

U-M study uncovers key to how 'triggering event' in cancer occurs

ANN ARBOR, Mich. Researchers at the University of Michigan Comprehensive Cancer Center have discovered what leads to two genes fusing together, a phenomenon that has been shown to cause prostate cancer to develop. The study...

powered by

WAGE promotes cancer awareness

Expert shares ways college students can lower risk Issue date: 10/29/09 Section: Don't think you're at risk for cancer? Smith, the Director of Cancer Services at Sacred Heart Hospital, spoke to students Monday about college...

powered by

Sex without nipples

What doctors rarely tell women with breast cancer: Just because you have the same equipment doesn't mean it works What came between Jessie and her boyfriend of seven years was nipples. When Jessie herself tested positive for...

powered by